
It’s been a bad week for several large pharmaceutical companies this week, with some major failures in clinical trials that …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

